Weight, this is easy question. Next earning release (early March) we'll probably get explanation about meeting with FDA and MAYBE partnership. Before that, maybe we'll learn if CLDX going to take part in ASCO and what it is going to present (and this is going to be strong catalyst, BTW, because they can present only something new at ASCO. So, if they're coming then it means there more positive news on horizon...)
I hope we get a catalyst before then like AACR. The Roth analyst (Joe P) will have egg on his face if CLDX does not get somewhat close to his call of $16. On Wednesday you should post your call for this Friday. I believe your current target is $8.